Literature DB >> 7602830

[Present status of idiopathic interstitial pneumonia--from epidemiology to etiology].

M Munakata1, M Asakawa, Y Hamma, Y Kawakami.   

Abstract

The present status of idiopathic interstitial pneumonia (IIP) was evaluated from data collected as part of the Financial Support Program for patients with IIP, conducted in Hokkaido since 1979. The prevalence of IIP in 1992 was 4.08/100,000, and the yearly incidence was 1.23/100,000. The ratio of men to women was 1.85/1.0. Under age 55, women were more numerous than men, and over age 55, men were more numerous than women. Clinical and epidemiological analyses of the patients with IIP, with collagen vascular disease-interstitial pneumonia suggested possible contribution of dust inhalation to the etiology IIP. A prospective study revealed that about 20% of the subjects had systemic signs and symptoms of collagen diseases from 2 months to 10 years after the diagnosis of IIP. In addition, about 15% of the subjects with IIP developed lung cancer during the follow-up period. This incidence was significantly higher than that in the patients with chronic obstructive pulmonary diseases and the same smoking history, which suggests that IIP itself is a risk factor for lung cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7602830

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  6 in total

Review 1.  The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.

Authors:  Giulia Maria Stella; Vito D'Agnano; Davide Piloni; Laura Saracino; Sara Lettieri; Francesca Mariani; Andrea Lancia; Chandra Bortolotto; Pietro Rinaldi; Francesco Falanga; Cristiano Primiceri; Angelo Guido Corsico; Andrea Bianco
Journal:  Transl Lung Cancer Res       Date:  2022-03

2.  Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata study.

Authors:  Hiroshi Nakano; Yoko Shibata; Sumito Inoue; Akira Igarashi; Keiko Yamauchi; Shuichi Abe; Masamichi Sato; Yasuko Aida; Keiko Nunomiya; Tomomi Kimura; Takako Nemoto; Tetsu Watanabe; Tsuneo Konta; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

Review 3.  Cell-Based Therapies for Tissue Fibrosis.

Authors:  Rebecca Lim; Sharon D Ricardo; William Sievert
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

Review 4.  Interstitial Lung Diseases in Developing Countries.

Authors:  Pilar Rivera-Ortega; Maria Molina-Molina
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

Review 5.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

6.  Relationship between plasma fibrinogen levels and pulmonary function in the japanese population: the Takahata study.

Authors:  Yoko Shibata; Shuichi Abe; Sumito Inoue; Akira Igarashi; Keiko Yamauchi; Yasuko Aida; Hiroyuki Kishi; Keiko Nunomiya; Hiroshi Nakano; Masamichi Sato; Kento Sato; Tomomi Kimura; Takako Nemoto; Tetsu Watanabe; Tsuneo Konta; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  Int J Med Sci       Date:  2013-09-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.